这是一篇来自已证抗体库的有关小鼠 Tgm2的综述,是根据9篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Tgm2 抗体。
Tgm2 同义词: TG2; TGase2; tTG; tTGas; protein-glutamine gamma-glutamyltransferase 2; C polypeptide; TG(C); TGC; TGase C; TGase-2; protein-glutamine-gamma-glutamyltransferase; tissue transglutaminase; transglutaminase C; transglutaminase-2

艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫组化; 小鼠; 1:250
艾博抗(上海)贸易有限公司 Tgm2抗体(Abcam, ab421)被用于被用于免疫组化在小鼠样品上浓度为1:250. Mol Cell Neurosci (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司 Tgm2抗体(Abcam, ab421)被用于被用于免疫印迹在人类样品上浓度为1:1000. Exp Cell Res (2013) ncbi
兔 多克隆
  • 免疫组化基因敲除验证; 小鼠; 1:50; 图 1
艾博抗(上海)贸易有限公司 Tgm2抗体(Abcam, ab421)被用于被用于免疫组化基因敲除验证在小鼠样品上浓度为1:50 (图 1). Biochim Biophys Acta (2013) ncbi
赛信通(上海)生物试剂有限公司
兔 单克隆(D11A6)
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 Tgm2抗体(Cell Signaling Technology, 3557)被用于被用于免疫印迹在小鼠样品上 (图 4a). Cell Rep (2018) ncbi
兔 单克隆(D11A6)
  • 免疫印迹; 小鼠; 1:1000; 图 1f
赛信通(上海)生物试剂有限公司 Tgm2抗体(Cell Signaling, D11A6)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 1f). Mol Biol Cell (2018) ncbi
兔 单克隆(D11A6)
  • 免疫印迹基因敲除验证; 小鼠; 图 4a
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司 Tgm2抗体(Cell Signaling, D11A6)被用于被用于免疫印迹基因敲除验证在小鼠样品上 (图 4a) 和 被用于免疫印迹在人类样品上 (图 4b). Biochim Biophys Acta (2016) ncbi
兔 单克隆(D11A6)
  • 免疫印迹; 小鼠; 1:500; 表 4
赛信通(上海)生物试剂有限公司 Tgm2抗体(Cell Signaling Technology, 3557S)被用于被用于免疫印迹在小鼠样品上浓度为1:500 (表 4). PLoS ONE (2014) ncbi
默克密理博中国
山羊 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:4000; 图 1
默克密理博中国 Tgm2抗体(Millipore, 06471)被用于被用于免疫组化-冰冻切片在小鼠样品上浓度为1:4000 (图 1). Sci Rep (2016) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:50
  • 免疫印迹; 小鼠; 1:1000
  • 免疫组化-石蜡切片; 人类; 1:50
  • 免疫印迹; 人类; 1:1000
默克密理博中国 Tgm2抗体(Upstate, 06-471)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50, 被用于免疫印迹在小鼠样品上浓度为1:1000, 被用于免疫组化-石蜡切片在人类样品上浓度为1:50 和 被用于免疫印迹在人类样品上浓度为1:1000. Eur Respir J (2014) ncbi
文章列表
  1. D Eletto M, Rossin F, Occhigrossi L, Farrace M, Faccenda D, Desai R, et al. Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. Cell Rep. 2018;25:3573-3581.e4 pubmed 出版商
  2. Li R, Serrano J, Xing H, Lee T, Azizgolshani H, Zaman M, et al. Interstitial flow promotes macrophage polarization toward an M2 phenotype. Mol Biol Cell. 2018;29:1927-1940 pubmed 出版商
  3. Diaz Hidalgo L, Altuntas S, Rossin F, D Eletto M, Marsella C, Farrace M, et al. Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions. Biochim Biophys Acta. 2016;1863:2084-92 pubmed 出版商
  4. Wilhelmus M, de Jager M, Smit A, van der Loo R, Drukarch B. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models. Sci Rep. 2016;6:20569 pubmed 出版商
  5. Hohsfield L, Daschil N, Orädd G, Strömberg I, Humpel C. Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models. Mol Cell Neurosci. 2014;63:83-95 pubmed
  6. Menalled L, Kudwa A, Oakeshott S, Farrar A, Paterson N, Filippov I, et al. Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease. PLoS ONE. 2014;9:e99520 pubmed 出版商
  7. Witsch T, Niess G, Sakkas E, Likhoshvay T, Becker S, Herold S, et al. Transglutaminase 2: a new player in bronchopulmonary dysplasia?. Eur Respir J. 2014;44:109-21 pubmed 出版商
  8. Hou A, Voorhoeve P, Lan W, Tin M, Tong L. Comparison of gene expression profiles in primary and immortalized human pterygium fibroblast cells. Exp Cell Res. 2013;319:2781-9 pubmed 出版商
  9. Tong L, Png E, Aihua H, Yong S, Yeo H, Riau A, et al. Molecular mechanism of transglutaminase-2 in corneal epithelial migration and adhesion. Biochim Biophys Acta. 2013;1833:1304-15 pubmed 出版商